Company Filing History:
Years Active: 1994
Title: **Innovator Spotlight: Elizabeth R. Oldham**
Introduction
Elizabeth R. Oldham is a notable inventor based in Newtown, Pennsylvania. With a focus on the biopharmaceutical field, she has contributed significantly to the development of therapeutic compositions aimed at treating mammalian diseases.
Latest Patents
Elizabeth holds one patent titled "Compositions for the treatment of mammalian diseases." This patent describes a groundbreaking therapeutic composition that includes a potentiating or safening amount of an aqueous surfactant combined with a bactericidal agent and/or a biological response modifier. The disclosure also details an improved method for treating mastitis by administering this composition to afflicted mammals. Moreover, it describes a method for screening suitable formulations for treating infectious diseases, showcasing Elizabeth's commitment to advancing healthcare solutions.
Career Highlights
Elizabeth R. Oldham is affiliated with the American Cyanamid Company, where she has been instrumental in pioneering research that has led to her patented innovations. Her work is not only influential for its scientific merit but also for its practical applications in treating conditions that affect livestock and other mammals.
Collaborations
In her professional journey, Elizabeth has collaborated with esteemed colleagues, including Michael Joseph Daley and William David Steber. These collaborations have enhanced the research environment and have played a vital role in the success of her innovative endeavors.
Conclusion
Elizabeth R. Oldham exemplifies the spirit of innovation through her contributions in the field of therapeutic compositions. Her patent not only represents a significant achievement in her career but also has the potential to make impactful improvements in the treatment of mammalian diseases. Her work at the American Cyanamid Company and collaborative efforts with her coworkers underline the importance of teamwork in driving progress in scientific research and innovation.